2. Academic Validation
  3. 3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. part 2: optimization of the side chains to improve in vitro and in vivo potencies

3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. part 2: optimization of the side chains to improve in vitro and in vivo potencies

  • Bioorg Med Chem. 2010 Feb 15;18(4):1641-58. doi: 10.1016/j.bmc.2009.12.068.
Masaki Asada 1,  Maki Iwahashi,  Tetsuo Obitsu,  Atsushi Kinoshita,  Yoshihiko Nakai,  Takahiro Onoda,  Toshihiko Nagase,  Motoyuki Tanaka,  Yoshiyuki Yamaura,  Hiroya Takizawa,  Ken Yoshikawa,  Kazutoyo Sato,  Masami Narita,  Shuichi Ohuchida,  Hisao Nakai,  Masaaki Toda
Affiliations

Affiliation

  • 1 Minase Research Institute, Ono Pharmaceutical Co., Ltd, Shimamoto, Mishima, Osaka 618-8585, Japan. [email protected]
PMID: 20129791 DOI: 10.1016/j.bmc.2009.12.068
Abstract

A series of 3-[2-{[(3-methyl-1-phenylbutyl)amino]carbonyl}-4-(phenoxymethyl)phenyl]propanoic acid analogs were synthesized and evaluated for their in vitro potency. In most cases, introduction of one or two substituents into the two phenyl moieties resulted in the tendency of an increase or retention of in vitro activities. Several compounds, which showed excellent subtype selectivity, were evaluated for their inhibitory effect against PGE(2)-induced uterine contraction in pregnant rats, which is thought to be mediated by the EP3 receptor subtype. The structure-activity relationships (SARs) are also discussed.

Figures
Products